Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. - Wikidata - wikimedia - TriplyDB

Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

http://www.wikidata.org/entity/Q43707366

about

Modern imaging techniques for preoperative detection of distant metastases in gastric cancer Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma.Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer.GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.Diagnosis and evaluation of gastric cancer by positron emission tomography The role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancer Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma Current concepts on dedifferentiation/high-grade transformation in salivary gland tumors.GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis.The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer Microenvironmental and cellular consequences of altered blood flow in tumours.Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively 18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients.Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer.The role of positron emission tomography in esophageal cancer.

P2860

Q26784453-CAC1F999-0B2F-4F3B-921A-50BF11BF87DF Q28077883-04B0DE63-8DBA-4409-9EA4-3F40557226C7 Q28389539-9B632F90-323C-418A-8906-13D6AB3A95F5 Q30241566-8121286A-EF27-4A79-B6D2-A2E828D169CF Q33583028-2ABB8F1E-5F6A-4547-9D52-8AA561C73019 Q33704181-EEAAA5FF-F3B3-4FDE-8925-2A694670B4D6 Q33704435-8BC4A5CF-B14E-4E7E-84F4-4B09403A5863 Q33704511-AC2D2B42-B622-4013-B4AD-6F7F934D20C2 Q33714473-7CBAD380-ED5D-4F82-B9C8-85E6ADDBBA50 Q33727137-2E1182DA-5DB8-49D5-A795-9D652BA9350B Q33889236-E563F7B8-2BF8-4A39-98CA-DBC9BC260AA9 Q34204238-B0F2923E-B0F8-4B7B-84E0-6AB613C33AA2 Q34310486-4A32B05A-2A83-4283-8826-A14919D5729D Q34326615-676BC958-FB45-460E-BF04-9C6B3499FD32 Q34506646-01DDABAB-1E79-4E1B-A4D3-1ADAF8F4D850 Q34627053-D0FA6606-C812-4C20-B886-08D28C835681 Q34661633-C8090F9B-3A79-422D-8D81-4C966E3DDB31 Q34666869-36E97E4E-CBEA-474B-92E6-C85727D6D743 Q34672640-730BB2D1-18AD-4929-B35E-737A3C02F647 Q34831255-E4156F13-7439-4F49-A79A-CE22D988FEE3 Q35127213-F398CCBB-29AA-4AE6-955F-FECB0AC564D2 Q35167655-BD30BAD6-4CE5-4FBB-AD13-844BEEC1E72A Q35176500-CE680404-04BB-493D-B81A-8197604C3088 Q35188024-21C747FE-78D1-45F9-9988-F30D3C93C92E Q35214843-A433CD75-DBD6-42C3-ACCD-1AB8D0AB388A Q35670459-A71D38AD-E19F-4168-BB9E-5247A6D2D2C8 Q35724980-96A35B2F-76B6-436D-9123-0A523228593B Q35857879-38F25F29-F269-4D4C-AADD-24D0186BE44C Q35902612-0CDD4749-89DE-4DE4-BAE1-01283DA0F4A4 Q35904989-055E0601-95B9-48FC-98C7-E16355BEA6F0 Q35928789-318FDB67-F444-49F7-BFC1-507001FAC6D5 Q36064169-00C4086E-B5C6-4B69-9E58-4F8E8D75A520 Q36142620-839153B8-4238-4F66-80DF-EFDAC40240D0 Q36218208-5AC465F5-EAEF-4298-92F6-9A263F257C5E Q36319461-671C0E52-6AA5-4E0E-B891-5F729E253057 Q36323245-3B56A44B-F5FC-4201-A7B3-B43123AE93F0 Q36494154-C5E54A02-298D-4B64-BA0F-50B57DFB1863 Q36901233-09C19914-04D6-40A4-AC9A-36A2A81DABD6 Q36936849-91110F94-7F99-4C91-A2C4-E71F8ECD364D Q37072481-43F8A14A-97EB-4862-B4D6-7F4B290DC9FA

P2860

Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

http://www.wikidata.org/entity/Q43707366

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Expression of glucose transpor ...... astasis, and patient survival.

@en

Expression of glucose transpor ...... astasis, and patient survival.

@nl

type

label

Expression of glucose transpor ...... astasis, and patient survival.

@en

Expression of glucose transpor ...... astasis, and patient survival.

@nl

prefLabel

Expression of glucose transpor ...... astasis, and patient survival.

@en

Expression of glucose transpor ...... astasis, and patient survival.

@nl

P1433

Q43707366-D2654026-8581-41D6-A112-83A04786A7D2

P1476

Q43707366-795FC8AF-72A8-4362-BA21-71E80784476F

P2093

Q43707366-04191EC8-2790-4F50-85FA-B38DDAAAE777

Q43707366-5723CE6D-E60A-48EE-AEBE-19B29413E477

Q43707366-6A052639-F95F-4DB3-BC6C-0847AA80D07F

Q43707366-70EEE70D-4A2D-4884-B5CB-CCB45F145EA9

Q43707366-73B54097-2739-414E-9BE0-1E6456072321

Q43707366-748DE06C-4228-4C71-834E-F6414F50A430

Q43707366-9082B86B-4268-4A13-90DF-558AA785C2F1

Q43707366-DFE6608C-AF15-4728-A9D4-C4D29819403E

P2860

Q43707366-0054C22C-3BF8-4E6B-A890-F796FBDF7755

Q43707366-10CF4144-F03A-4032-890D-C038463D7343

Q43707366-16C752AB-B15D-4ED2-A8EA-4D6B9C1A1DAB

Q43707366-29F74AE5-AC62-4FB6-B7B6-BF20693E7007

Q43707366-40A95B50-22E7-4B43-AED2-CE04543512DC

Q43707366-460113A8-EC37-4137-99D5-2677FC0534A9

Q43707366-4C395C21-1070-49BE-B3B1-437A9F238AA8

Q43707366-5295004B-B52D-45A7-89DA-2EF440DD230D

Q43707366-533A6D73-7DB0-4D2D-AD54-FC6FBA01643C

Q43707366-70D1FFC9-5371-47B8-92D4-9D4D21BEAD3F

P304

Q43707366-FE9B8A38-64F1-48B8-85B8-34E9617F41CC

P31

Q43707366-C1BA9B16-52FA-4B2A-9FAD-A0B7B8E205B9

P356

Q43707366-359812FC-8EBD-440F-A576-2E13AEB8C86F

P407

Q43707366-087A41C1-9CFB-4323-BD12-6922C128093D

P433

Q43707366-0FBB3BC3-BFC4-4499-8C5A-961B7FDF3FD4

P478

Q43707366-E007EB71-EAD8-48F1-ADDB-F55096DF2981

P577

Q43707366-F5E9C0FF-1FA3-465E-8F4C-DB4157B91BAF

P698

Q43707366-CF375487-C4C9-4994-8803-1A173ED3ABAA

P921

Q43707366-7B1AE2D6-3301-45ED-9A55-A811F10C261D

Q43707366-E501000D-36B7-47C3-8EBC-AA2A7BC0B0AC

Q43707366-d8893564-db9e-4dc6-8c34-3c41b4e1f517

P356

1097-0142(20010801)92:3%3C634::AID-CNCR1364%3E3.0.CO;2-X

P1433

P1476

Expression of glucose transpor ...... astasis, and patient survival.

@en

P2093

Fukuda T

http://www.w3.org/2001/XMLSchema#string

Honma K

http://www.w3.org/2001/XMLSchema#string

Kawamura T

http://www.w3.org/2001/XMLSchema#string

Kusakabe T

http://www.w3.org/2001/XMLSchema#string

Nashimoto A

http://www.w3.org/2001/XMLSchema#string

Sugino T

http://www.w3.org/2001/XMLSchema#string

Suzuki T

http://www.w3.org/2001/XMLSchema#string

Watanabe K

http://www.w3.org/2001/XMLSchema#string

P2860

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein.

Application of metabolic-control logic to fuel utilization and its significance in tumor cells.

Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.

Regulation of the glucose transporter GLUT1 in mammalian cells.

Facilitative glucose transporters.

Growth factors, mitogens, oncogenes and the regulation of glucose transport.

Metabolic regulation of glucose transport.

P304

634-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11505409

http://www.w3.org/2001/XMLSchema#string

P921